Life-Sciences-USA.com
The Transatlantic Life Sciences Web Portal

This is a free web portal for the life sciences in North America, Europe and Israel... » read more

Forbion: Dirk Kersten Now Managing Partner; US Expansion (2025-01-13)
> Dirk Kersten promoted to Managing Partner, further strengthening firm’s leadership > Jonathan McNeill, M.D. joins Forbion as Partner in the Boston office Forbion, a leading global life sciences venture capital firm with expertise in Europe, is delighted...
Candid Tx Licenses Trispecific T-cell Engager from WuXi (2025-01-13)
Candid Therapeutics, Inc. (“Candid”), a clinical-stage biotechnology company focused on becoming the leader in advancing T-cell engagers for autoimmune and inflammatory diseases, announced today an agreement with WuXi Biologics under which Candid will have excl...
JnJ to Acquire Intra-Cellular Therapies for $14.6b in Cash (2025-01-13)
> Acquisition includes CAPLYTA® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and monotherapy; also approved for the treatment of schizophrenia in adults > sNDA submitted to U.S. FDA for CAPLYTA�...
GSK to Acquire IDRx for $1b Upfront plus $150m Milestones (2025-01-13)
> Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST) > IDRX-42 offers potential to address all key KIT mutations in GIST that drive tumour growth and progression and impr...
Windward Bio: $200m Series A & License to TSLP Ab from China (2025-01-10)
> Highly experienced management team with a successful track record in advancing compounds from target identification to commercialization > Top-tier global investors fund the company through clinical proof of concept of its lead program and IND-enablement of bi...
BioLizard Welcomes Arjan van Manen as Commercial Director (2025-01-09)
> Arjan van Manen joins BioLizard as Commercial Director, bringing over 20 years of commercial leadership experience in life sciences > Meet BioLizard’s Arjan van Manen and CEO Liesbeth Ceelen at Biotech Showcase during JP Morgan Week (Jan 13-15, 2025) in San ...
Ori Biotech Expands Management Team and Advisory Board (2025-01-09)
Company Making Additions to Executive Team and Advisory Board to Support Significant Commercial Momentum Oribiotech Ltd (Ori), a leader in cell and gene therapy (CGT) manufacturing technology, today announces new additions to its leadership, including the appo...
Bio Drug Delivery Firm LifeActive Bio Emerges from Stealth (2025-01-09)
> Novel Molecular Administration Platform™ Penetrates Skin Barrier, Encapsulates and Delivers Molecules into Blood Stream > Company Pursues Skin-Penetrating Companion Therapeutics for Biologics and Small Molecule Drugs > R&D and Investor Day to be Held Duri...
Coave Tx: €32m Series A Led by Novo Holdings & Bpifrance (2025-01-09)
> Financing co-led by Novo Holdings A/S and Bpifrance (as part of the InnoBio investment strategy) and joined by leading US and EU investors Invus and UI Investissement alongside existing investors > Proceeds to advance Coave’s proprietary ALIGATER™ platform...
Numab Therapeutics Closes CHF50m Series C Extension (2025-01-09)
> CHF 50 Million extension round co-led by Cormorant Asset Management, with participation from other existing investors > Proceeds will be used to support the advancement of multiple first-in-class and best-in-class programs into clinical development Numa...

Life-Sciences-USA.com is your doorway to the Transatlantic life sciences!

[LSUS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the North America, Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUS] is 100% Made in Germany!

» Start here with the latest News!

Picture Swiss Biotech Association Swiss Biotech Days 2025 SBD25 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]